Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study.
Ezpeleta G, Navascués A, Viguria N, Herranz-Aguirre M, Juan Belloc SE, Gimeno Ballester J, Muruzábal JC, García-Cenoz M, Trobajo-Sanmartín C, Echeverria A, Martínez-Baz I, Vera-Punzano N, Casado I, López-Mendoza H, Ezpeleta C, Castilla J.
Ezpeleta G, et al. Among authors: viguria n.
Vaccines (Basel). 2024 Apr 4;12(4):383. doi: 10.3390/vaccines12040383.
Vaccines (Basel). 2024.
PMID: 38675765
Free PMC article.